II期临床试验-话题@MedSci

#II期临床试验#

174篇内容 | 3264人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1931416, encodeId=ea6f19314165b, content=<a href='/topic/show?id=a3d89601f2' target=_blank style='color:#2F92EE;'>#II期临床试验#</a>, objectTitle=Lancet子刊：2型糖尿病新药trelagliptin III期临床试验结果乐观, objectType=article, longId=45947, objectId=66654594e34, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66654594e34, replyNumber=0, likeNumber=70, createdTime=2015-04-23, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66654594e34, moduleTitle=Lancet子刊：2型糖尿病新药trelagliptin III期临床试验结果乐观, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66654594e34)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1931414, encodeId=9f191931414e1, content=<a href='/topic/show?id=a3d89601f2' target=_blank style='color:#2F92EE;'>#II期临床试验#</a>, objectTitle=汤森路透：五个进入II期临床试验的更具前景药物品种, objectType=article, longId=41019, objectId=db344101960, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db344101960, replyNumber=0, likeNumber=68, createdTime=2015-03-22, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db344101960, moduleTitle=汤森路透：五个进入II期临床试验的更具前景药物品种, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db344101960)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1931412, encodeId=8981193141287, content=<a href='/topic/show?id=a3d89601f2' target=_blank style='color:#2F92EE;'>#II期临床试验#</a>, objectTitle=Lancet Oncol：S-1联合奥沙利铂与卡培他滨联合奥沙利铂一线治疗转移性结直肠癌患者：一项III期临床试验的全新结果, objectType=article, longId=37049, objectId=a8b93e049a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8b93e049a1, replyNumber=0, likeNumber=0, createdTime=2014-12-09, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8b93e049a1, moduleTitle=Lancet Oncol：S-1联合奥沙利铂与卡培他滨联合奥沙利铂一线治疗转移性结直肠癌患者：一项III期临床试验的全新结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8b93e049a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1931408, encodeId=3a29193140847, content=<a href='/topic/show?id=a3d89601f2' target=_blank style='color:#2F92EE;'>#II期临床试验#</a>, objectTitle=ASCO 2014：贝伐单抗加化疗用于直肠癌术前治疗的II期临床试验, objectType=article, longId=35259, objectId=6fa835259a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fa835259a8, replyNumber=0, likeNumber=73, createdTime=2014-11-27, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fa835259a8, moduleTitle=ASCO 2014：贝伐单抗加化疗用于直肠癌术前治疗的II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fa835259a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1931411, encodeId=b288193141177, content=<a href='/topic/show?id=a3d89601f2' target=_blank style='color:#2F92EE;'>#II期临床试验#</a>, objectTitle=Gynecol Oncol：吉非替尼联合S-1与卡铂一线治疗发生表皮生长因子受体突变的晚期非小细胞肺癌患者的II期临床试验, objectType=article, longId=37047, objectId=6eb73e0471c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6eb73e0471c, replyNumber=0, likeNumber=65, createdTime=2015-06-08, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6eb73e0471c, moduleTitle=Gynecol Oncol：吉非替尼联合S-1与卡铂一线治疗发生表皮生长因子受体突变的晚期非小细胞肺癌患者的II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6eb73e0471c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1931409, encodeId=0ec7193140957, content=<a href='/topic/show?id=a3d89601f2' target=_blank style='color:#2F92EE;'>#II期临床试验#</a>, objectTitle=ASCO 2014：MSC2156119J+吉非替尼治疗MET阳性EGFR突变晚期NSCLC的I/II期临床试验, objectType=article, longId=35667, objectId=f1cf3566e12, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1cf3566e12, replyNumber=0, likeNumber=65, createdTime=2014-08-10, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1cf3566e12, moduleTitle=ASCO 2014：MSC2156119J+吉非替尼治疗MET阳性EGFR突变晚期NSCLC的I/II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1cf3566e12)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1931410, encodeId=052319314102e, content=<a href='/topic/show?id=a3d89601f2' target=_blank style='color:#2F92EE;'>#II期临床试验#</a>, objectTitle=BMJ：新型抗结核三联方案PaMZ III期临床试验即将启动, objectType=article, longId=36188, objectId=2cdb361889b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cdb361889b, replyNumber=0, likeNumber=76, createdTime=2014-06-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cdb361889b, moduleTitle=BMJ：新型抗结核三联方案PaMZ III期临床试验即将启动, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cdb361889b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1931407, encodeId=9dfe193140e4e, content=<a href='/topic/show?id=a3d89601f2' target=_blank style='color:#2F92EE;'>#II期临床试验#</a>, objectTitle=NEJM：阿尔茨海默病新药Solanezumab III期临床试验失败, objectType=article, longId=30355, objectId=46a930355d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46a930355d0, replyNumber=0, likeNumber=64, createdTime=2014-11-06, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46a930355d0, moduleTitle=NEJM：阿尔茨海默病新药Solanezumab III期临床试验失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46a930355d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1931406, encodeId=f2531931406a9, content=<a href='/topic/show?id=a3d89601f2' target=_blank style='color:#2F92EE;'>#II期临床试验#</a>, objectTitle=国产艾滋疫苗进入II期临床试验, objectType=article, longId=21936, objectId=21be2193686, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21be2193686, replyNumber=0, likeNumber=59, createdTime=2014-02-09, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21be2193686, moduleTitle=国产艾滋疫苗进入II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21be2193686)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1931405, encodeId=babf193140517, content=<a href='/topic/show?id=a3d89601f2' target=_blank style='color:#2F92EE;'>#II期临床试验#</a>, objectTitle=阿斯利康旗下三个靶向肿瘤药物进入III期临床试验, objectType=article, longId=19185, objectId=10d619185bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10d619185bd, replyNumber=0, likeNumber=88, createdTime=2014-04-02, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10d619185bd, moduleTitle=阿斯利康旗下三个靶向肿瘤药物进入III期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10d619185bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1931403, encodeId=cb2a1931403f3, content=<a href='/topic/show?id=a3d89601f2' target=_blank style='color:#2F92EE;'>#II期临床试验#</a>, objectTitle=狄诺塞麦有助于男性提高骨密度-III期临床试验结果, objectType=article, longId=8307, objectId=3380830e6c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3380830e6c, replyNumber=0, likeNumber=53, createdTime=2013-05-07, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3380830e6c, moduleTitle=狄诺塞麦有助于男性提高骨密度-III期临床试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3380830e6c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1931401, encodeId=bb301931401a8, content=<a href='/topic/show?id=a3d89601f2' target=_blank style='color:#2F92EE;'>#II期临床试验#</a>, objectTitle=Helix公司外用干扰素α-2b获批开展III期临床试验, objectType=article, longId=6477, objectId=dd7764e791, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd7764e791, replyNumber=0, likeNumber=85, createdTime=2013-01-12, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd7764e791, moduleTitle=Helix公司外用干扰素α-2b获批开展III期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd7764e791)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1931404, encodeId=942b193140411, content=<a href='/topic/show?id=a3d89601f2' target=_blank style='color:#2F92EE;'>#II期临床试验#</a>, objectTitle=Jennerex启动JX-594在晚期肝癌患者的II期临床试验, objectType=article, longId=8433, objectId=14d184330d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14d184330d, replyNumber=0, likeNumber=61, createdTime=2012-12-11, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14d184330d, moduleTitle=Jennerex启动JX-594在晚期肝癌患者的II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14d184330d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1931402, encodeId=75ee19314027e, content=<a href='/topic/show?id=a3d89601f2' target=_blank style='color:#2F92EE;'>#II期临床试验#</a>, objectTitle=杨森启动ADX71149在重度抑郁症患者的II期临床试验, objectType=article, longId=6980, objectId=bc6d698058, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc6d698058, replyNumber=0, likeNumber=67, createdTime=2013-03-09, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc6d698058, moduleTitle=杨森启动ADX71149在重度抑郁症患者的II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc6d698058)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

II期临床试验

2020-05-29

kksonne (审核中...)

前往app查看评论内容

#II期临床试验#

Lancet子刊：2型糖尿病新药trelagliptin III期临床试验结果乐观

2015-04-23

kksonne (审核中...)

前往app查看评论内容

#II期临床试验#

汤森路透：五个进入II期临床试验的更具前景药物品种

2015-03-22

kksonne (审核中...)

前往app查看评论内容

#II期临床试验#

Lancet Oncol：S-1联合奥沙利铂与卡培他滨联合奥沙利铂一线治疗转移性结直肠癌患者：一项III期临床试验的全新结果

2014-12-09

kksonne (审核中...)

前往app查看评论内容

#II期临床试验#

ASCO 2014：贝伐单抗加化疗用于直肠癌术前治疗的II期临床试验

2014-11-27

kksonne (审核中...)

前往app查看评论内容

#II期临床试验#

Gynecol Oncol：吉非替尼联合S-1与卡铂一线治疗发生表皮生长因子受体突变的晚期非小细胞肺癌患者的II期临床试验

2015-06-08

kksonne (审核中...)

前往app查看评论内容

#II期临床试验#

ASCO 2014：MSC2156119J+吉非替尼治疗MET阳性EGFR突变晚期NSCLC的I/II期临床试验

2014-08-10

kksonne (审核中...)

前往app查看评论内容

#II期临床试验#

BMJ：新型抗结核三联方案PaMZ III期临床试验即将启动

2014-06-24

kksonne (审核中...)

前往app查看评论内容

#II期临床试验#

NEJM：阿尔茨海默病新药Solanezumab III期临床试验失败

2014-11-06

kksonne (审核中...)

前往app查看评论内容

#II期临床试验#

国产艾滋疫苗进入II期临床试验

2014-02-09

kksonne (审核中...)

前往app查看评论内容

#II期临床试验#

阿斯利康旗下三个靶向肿瘤药物进入III期临床试验

2014-04-02

kksonne (审核中...)

前往app查看评论内容

#II期临床试验#

狄诺塞麦有助于男性提高骨密度-III期临床试验结果

2013-05-07

kksonne (审核中...)

前往app查看评论内容

#II期临床试验#

Helix公司外用干扰素α-2b获批开展III期临床试验

2013-01-12

kksonne (审核中...)

前往app查看评论内容

#II期临床试验#

Jennerex启动JX-594在晚期肝癌患者的II期临床试验

2012-12-11

kksonne (审核中...)

前往app查看评论内容

#II期临床试验#

杨森启动ADX71149在重度抑郁症患者的II期临床试验

2013-03-09

科室
- - 订阅+
  - 更多科室
工具
服务